Learning Objectives:

• To increase the awareness of gastrointestinal mucositis and symptoms caused by cancer therapy
• To analyze different molecular pathways involved in the development of gastrointestinal mucositis by targeted agents and by immunotherapy and to compare them with the 2 pathogenesis of chemotherapy-induced gastrointestinal mucositis
• To define the essential information needed by HCPs to prevent and manage GI mucositis induced by these agents
• To discuss the needs in preclinical and clinical research in this field

Agenda:

• Introduction – Dr Paolo Bossi & Dr Hannah Wardill
• Mechanisms, Prevention and Management of GI Dysfunction Due to Immunotherapy – Dr Jervoise Andreyev
• HER-Targeted TKIs: Proposed Pathogenesis and Interventions for Digestive Symptoms – Prof Joanne Bowen
• Nutritional Consequences of GI Mucositis: How to Prevent and Manage Them – Ms Breeana Gardiner (to be added at a later date)

If you have any questions, please submit them to: 
Dr Paulo Bossi paolo.bossi@unibs.it
Dr Hannah Wardill hannah.wardill@adelaide.edu.au